TABLE 2.
Patient no. | Age (mo) | Day after onset of symptoms | Serum or plasma
|
|||||
---|---|---|---|---|---|---|---|---|
HHV-6 IgG titera
|
HHV-6 DNA | HHV-7 IgG titera
|
HHV-7 DNA | |||||
Without urea | With urea | Without urea | With urea | |||||
13 | 10 | 1c | 16 | NTb | − | <8 | NT | − |
14d | 2,048 | 32 | NT | 128 | <16 | NT | ||
14 | 12 | 3c | NT | NT | + | <8 | <8 | − |
4e | <16 | <16 | NT | NT | NT | NT | ||
19 | 2,048 | 64 | NT | 256 | <16 | NT |
Those sera whose antibody titers were reduced eightfold or greater by urea are defined as having low-avidity antibody and the results are highlighted in bold. Those sera whose titers were reduced fourfold or less by urea are defined as having high-avidity antibody.
NT, not tested.
Cerebrospinal fluid contained HHV-6 DNA but not HHV-7 DNA.
Saliva contained HHV-7 DNA but not HHV-6 DNA.
Saliva contained HHV-6 DNA and HHV-7 DNA.